October 2016 Member Publications

Selected Publications

1)     Practice Patterns in Postoperative Echocardiographic Surveillance after Congenital Heart Surgery in Children: A Single Center Experience.
Arunamata A, Axelrod DM, Kipps AK, McElhinney DB, Shin AY, Hanley FL, Olson IL, Roth SJ, Selamet Tierney ES.
J Pediatr. 2016 Oct 28.

2)     The Roles of Immunity in the Prevention and Evolution of Pulmonary Arterial Hypertension. A Perspective.
Nicolls MR, Voelkel NF.
Am J Respir Crit Care Med. 2016 Oct 27.

3)     Defective Signaling in the JAK-STAT Pathway Tracks with Chronic Inflammation and Cardiovascular Risk in Aging Humans.
Shen-Orr SS, Furman D, Kidd BA, Hadad F, Lovelace P, Huang YW, Rosenberg-Hasson Y, Mackey S, Grisar FA, Pickman Y, Maecker HT, Chien YH, Dekker CL, Wu JC, Butte AJ, Davis MM.
Cell Syst. 2016 Oct 26;3(4):374-384.e4.

4)     Prediction of 30-Day All-Cause Readmissions in Patients Hospitalized for Heart Failure: Comparison of Machine Learning and Other Statistical Approaches.
Frizzell JD, Liang L, Schulte PJ, Yancy CW, Heidenreich PA, Hernandez AF, Bhatt DL, Fonarow GC, Laskey WK.
JAMA Cardiol. 2016 Oct 26.

5)     iPSC Model of Pulmonary Arterial Hypertension Reveals Novel Gene Expression and Patient Specificity.
Sa S, Gu M, Chappell J, Shao NY, Ameen M, Elliott KA, Li D, Grubert F, Li CG, Taylor S, Cao A, Ma Y, Fong R, Nguyen L, Wu JC, Snyder MP, Rabinovitch M.
Am J Respir Crit Care Med. 2016 Oct 25.

6)     The Changing Landscape of Randomized Clinical Trials in Cardiovascular Disease.
Jones WS, Roe MT, Antman EM, Pletcher MJ, Harrington RA, Rothman RL, Oetgen WJ, Rao SV, Krucoff MW, Curtis LH, Hernandez AF, Masoudi FA.
J Am Coll Cardiol. 2016 Oct 25;68(17):1898-1907.

7)     Imputing gene expression to maximize platform compatibility.
Zhou W, Han L, Altman RB.
Bioinformatics. 2016 Oct 22.

8)     DNA damage-associated biomarkers in studying individual sensitivity to low-dose radiation from cardiovascular imaging.
Lee WH, Nguyen PK, Fleischmann D, Wu JC.
Eur Heart J. 2016 Oct 21;37(40):3075-3080.

9)     Pre-Transplantation Blockade of TNF-α-Mediated Oxygen Species Accumulation Protects Hematopoietic Stem Cells.
Ishida T, Suzuki S, Lai CY, Yamazaki S, Kakuta S, Iwakura Y, Nojima M, Takeuchi Y, Higashihara M, Nakauchi H, Otsu M.
Stem Cells. 2016 Oct 18.

10)   Exercise restrictions trigger psychological difficulty in active and athletic adults with hypertrophic cardiomyopathy.
Luiten RC, Ormond K, Post L, Asif IM, Wheeler MT, Caleshu C.
Open Heart. 2016 Oct 17;3(2):e000488.

11)   Combinatorial extracellular matrix microenvironments promote survival and phenotype of human induced pluripotent stem cell-derived endothelial cells in hypoxia.
Hou L, Coller J, Natu V, Hastie TJ, Huang NF.
Acta Biomater. 2016 Oct 15;44:188-99.

12)   TRANSFORM (Multicenter Experience With Rapid Deployment Edwards INTUITY Valve System for Aortic Valve Replacement) US clinical trial: Performance of a rapid deployment aortic valve.
Barnhart GR, Accola KD, Grossi EA, Woo YJ, Mumtaz MA, Sabik JF, Slachman FN, Patel HJ, Borger MA, Garrett HE Jr, Rodriguez E, McCarthy PM, Ryan WH, Duhay FG, Mack MJ, Chitwood WR Jr; TRANSFORM Trial Investigators.
J Thorac Cardiovasc Surg. 2016 Oct 15.

13)   Early somatic mosaicism is a rare cause of long-QT syndrome.
Priest JR, Gawad C, Kahlig KM, Yu JK, O'Hara T, Boyle PM, Rajamani S, Clark MJ, Garcia ST, Ceresnak S, Harris J, Boyle S, Dewey FE, Malloy-Walton L, Dunn K, Grove M, Perez MV, Neff NF, Chen R, Maeda K, Dubin A, Belardinelli L, West J, Antolik C, Macaya D, Quertermous T, Trayanova NA, Quake SR, Ashley EA.
Proc Natl Acad Sci U S A. 2016 Oct 11;113(41):11555-11560.

14)   Partial LVAD restores ventricular outputs and normalizes LV but not RV stress distributions in the acutely failing heart in silico.
Sack KL, Baillargeon B, Acevedo-Bolton G, Genet M, Rebelo N, Kuhl E, Klein L, Weiselthaler GM, Burkhoff D, Franz T, Guccione JM.
Int J Artif Organs. 2016 Oct 10;39(8):421-430.

15)   Laser-Assisted Removal of Embedded Vena Cava Filters: A 5-Year First-in-Human Study.
Kuo WT, Odegaard JI, Rosenberg JK, Hofmann LV.
Chest. 2016 Oct 8.

16)   Temporal Trends in Care and Outcomes of Patients Receiving Fibrinolytic Therapy Compared to Primary Percutaneous Coronary Intervention: Insights From the Get With The Guidelines Coronary Artery Disease (GWTG-CAD) Registry.
Hira RS, Bhatt DL, Fonarow GC, Heidenreich PA, Ju C, Virani SS, Bozkurt B, Petersen LA, Hernandez AF, Schwamm LH, Eapen ZJ, Albert MA, Liang L, Matsouaka RA, Peterson ED, Jneid H.
J Am Heart Assoc. 2016 Oct 6;5(10).

17)   Attenuation of synaptic toxicity and MARK4/PAR1-mediated Tau phosphorylation by methylene blue for Alzheimer's disease treatment.
Sun W, Lee S, Huang X, Liu S, Inayathullah M, Kim KM, Tang H, Ashford JW, Rajadas J.
Sci Rep. 2016 Oct 6;6:34784.

18)   Nat1 Deficiency Is Associated with Mitochondrial Dysfunction and Exercise Intolerance in Mice.
Chennamsetty I, Coronado M, Contrepois K, Keller MP, Carcamo-Orive I, Sandin J, Fajardo G, Whittle AJ, Fathzadeh M, Snyder M, Reaven G, Attie AD, Bernstein D, Quertermous T, Knowles JW.
Cell Rep. 2016 Oct 4;17(2):527-540.

19)   Tandem neopentyl glycol maltosides (TNMs) for membrane protein stabilisation.
Bae HE, Mortensen JS, Ribeiro O, Du Y, Ehsan M, Kobilka BK, Loland CJ, Byrne B, Chae PS.
Chem Commun (Camb). 2016 Oct 4;52(81):12104-12107.

20)   Rationale and design of Apo-I Event Reduction in Ischemic Syndromes I (AEGIS-I): A phase 2b, randomized, placebo-controlled, dose-ranging trial to investigate the safety and tolerability of CSL112, a reconstituted, infusible, human apoA-I, after acute myocardial infarction.
Gibson CM, Korjian S, Tricoci P, Daaboul Y, Alexander JH, Steg PG, Lincoff AM, Kastelein JJ, Mehran R, D'Andrea D, Merkely B, Zarebinski M, Ophius TO, Harrington RA.
Am Heart J. 2016 Oct;180:22-8.

21)   A Prospective Evaluation of Systemic Biomarkers and Cognitive Function Associated with Carotid Revascularization.
Zuniga MC, Tran TB, Baughman BD, Raghuraman G, Hitchner E, Rosen A, Zhou W.
Ann Surg. 2016 Oct;264(4):659-65.

22)   Surgical Unroofing of Hemodynamically Significant Left Anterior Descending Myocardial Bridges.
Boyd JH, Pargaonkar VS, Scoville DH, Rogers IS, Kimura T, Tanaka S, Yamada R, Fischbein MP, Tremmel JA, Mitchell RS, Schnittger I.
Ann Thorac Surg. 2016 Oct 1.

23)   "What's the Risk?" Assessing and Mitigating Risk in Cardiothoracic Surgery.
Lobdell KW, Fann JI, Sanchez JA.
Ann Thorac Surg. 2016 Oct;102(4):1052-8.

24)   Branched Endovascular Therapy of the Distal Aortic Arch: Preliminary Results of the Feasibility Multicenter Trial of the Gore Thoracic Branch Endoprosthesis.
Patel HJ, Dake MD, Bavaria JE, Singh MJ, Filinger M, Fischbein MP, Williams DM, Matsumura JS, Oderich G.
Ann Thorac Surg. 2016 Oct;102(4):1190-8.

25)   NETs Activate Pulmonary Arterial Endothelial Cells.
Rabinovitch M.
Arterioscler Thromb Vasc Biol. 2016 Oct;36(10):2035-7.

26)   Adaptive outflow boundary conditions improve post-operative predictions after repair of peripheral pulmonary artery stenosis.
Yang W, Feinstein JA, Vignon-Clementel IE.
Biomech Model Mechanobiol. 2016 Oct;15(5):1345-53.

27)   A multicentre randomized-controlled trial of inhaled milrinone in high-risk cardiac surgical patients.
Denault AY, Bussières JS, Arellano R, Finegan B, Gavra P, Haddad F, Nguyen AQ, Varin F, Fortier A, Levesque S, Shi Y, Elmi-Sarabi M, Tardif JC, Perrault LP, Lambert J.
Can J Anaesth. 2016 Oct;63(10):1140-53.

28)   Genetics and Genomics of Coronary Artery Disease.
Pjanic M, Miller CL, Wirka R, Kim JB, DiRenzo DM, Quertermous T.
Curr Cardiol Rep. 2016 Oct;18(10):102.

29)   Hypertriglyceridemia: A simple approach to identify insulin resistance and enhanced cardio-metabolic risk in patients with prediabetes.
Abbasi F, Kohli P, Reaven GM, Knowles JW.
Diabetes Res Clin Pract. 2016 Oct;120:156-61.

30)   Cloud-processed 4D CMR flow imaging for pulmonary flow quantification.
Chelu RG, Wanambiro KW, Hsiao A, Swart LE, Voogd T, van den Hoven AT, van Kranenburg M, Coenen A, Boccalini S, Wielopolski PA, Vogel MW, Krestin GP, Vasanawala SS, Budde RP, Roos-Hesselink JW, Nieman K.
Eur J Radiol. 2016 Oct;85(10):1849-56.

31)   Transforming the care of atrial fibrillation with mobile health.
Turakhia MP, Kaiser DW.
J Interv Card Electrophysiol. 2016 Oct;47(1):45-50.

32)   Dual-Modality Activity-Based Probes as Molecular Imaging Agents for Vascular Inflammation.
Withana NP, Saito T, Ma X, Garland M, Liu C, Kosuge H, Amsallem M, Verdoes M, Ofori LO, Fischbein M, Arakawa M, Cheng Z, McConnell MV, Bogyo M.
J Nucl Med. 2016 Oct;57(10):1583-1590.

33)   Effect of diastolic dysfunction on postoperative outcomes after cardiovascular surgery: A systematic review and meta-analysis.
Kaw R, Hernandez AV, Pasupuleti V, Deshpande A, Nagarajan V, Bueno H, Coleman CI, Ioannidis JP, Bhatt DL, Blackstone EH; Cardiovascular Meta-analyses Research Group.
J Thorac Cardiovasc Surg. 2016 Oct;152(4):1142-53.

34)   Temporal changes in biomarkers and their relationships to reperfusion and to clinical outcomes among patients with ST segment elevation myocardial infarction.
van Diepen S, Alemayehu WG, Zheng Y, Theroux P, Newby LK, Mahaffey KW, Granger CB, Armstrong PW.
J Thromb Thrombolysis. 2016 Oct;42(3):376-85.

35)   Biochemically engineered stromal cell-derived factor 1-alpha analog increases perfusion in the ischemic hind limb.
Edwards BB, Fairman AS, Cohen JE, MacArthur JW Jr, Goldstone AB, Woo JB, Hiesinger W, Woo YJ.
J Vasc Surg. 2016 Oct;64(4):1093-9.

36)   The Outlook of Digital Health for Cardiovascular Medicine: Challenges but Also Extraordinary Opportunities.
Turakhia MP, Desai SA, Harrington RA.
JAMA Cardiol. 2016 Oct 1;1(7):743-744.

37)   Adult Stem Cell Therapy and Heart Failure, 2000 to 2016: A Systematic Review.
Nguyen PK, Rhee JW, Wu JC.
JAMA Cardiol. 2016 Oct 1;1(7):831-841.

38)   iPSC-derived cardiomyocytes reveal abnormal TGF-β signalling in left ventricular non-compaction cardiomyopathy.
Kodo K, Ong SG, Jahanbani F, Termglinchan V, Hirono K, InanlooRahatloo K, Ebert AD, Shukla P, Abilez OJ, Churko JM, Karakikes I, Jung G, Ichida F, Wu SM, Snyder MP, Bernstein D, Wu JC.
Nat Cell Biol. 2016 Oct;18(10):1031-42.

39)   Single-cell multimodal profiling reveals cellular epigenetic heterogeneity.
Cheow LF, Courtois ET, Tan Y, Viswanathan R, Xing Q, Tan RZ, Tan DS, Robson P, Loh YH, Quake SR, Burkholder WF.
Nat Methods. 2016 Oct;13(10):833-6.

40)   Alternative approaches to generating cardiomyocytes are under development.
Chen IY, Matsa E, Wu JC.
Nat Rev Cardiol. 2016 Oct;13(10):574.

41)   Astrocytes: Integrative Regulators of Neuroinflammation in Stroke and Other Neurological Diseases.
Cekanaviciute E, Buckwalter MS.
Neurotherapeutics. 2016 Oct;13(4):685-701. Review.

42)   Perioperative management of pediatric en-bloc combined heart-liver transplants: a case series review.
Navaratnam M, Ng A, Williams GD, Maeda K, Mendoza JM, Concepcion W, Hollander SA, Ramamoorthy C.
Paediatr Anaesth. 2016 Oct;26(10):976-86.

43)    Interdisciplinary psychosocial care for families with inherited cardiovascular diseases.
Caleshu C, Kasparian NA, Edwards KS, Yeates L, Semsarian C, Perez M, Ashley E, Turner CJ, Knowles JW, Ingles J.
Trends Cardiovasc Med. 2016 Oct;26(7):647-53